We understand that people with cancer are worried about coronavirus. Here is the latest guidance. We will update it regularly.

Publications directory

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 141

Cover image of 'Letrozole (Femara®) [Portuguese]'

Letrozole (Femara®) [Portuguese] (July 2018)

Macmillan Cancer Support

Letrozole is a hormonal therapy used in the treatment of post-menopausal women with breast cancer. This factsheet describes how it works, how it is given, and the possible side-effects.

Cover image of 'Tamoxifen [Portuguese]'

Tamoxifen [Portuguese] (2018)

Macmillan Cancer Support

Tamoxifen is a hormone therapy used in the treatment of breast cancer. This factsheet describes how it works, how it is given, and the possible side-effects.

Cover image of 'Letrozole (Femara®) [Lithuanian]'

Letrozole (Femara®) [Lithuanian] (July 2018)

Macmillan Cancer Support

Letrozole is a hormonal therapy used in the treatment of post-menopausal women with breast cancer. This factsheet describes how it works, how it is given, and the possible side-effects.

Cover image of 'Letrozole (Femara®) [Polish]'

Letrozole (Femara®) [Polish] (July 2018)

Macmillan Cancer Support

Letrozole is a hormonal therapy used in the treatment of post-menopausal women with breast cancer. This factsheet describes how it works, how it is given, and the possible side-effects.

Cover image of 'ATRA and anthracycline based therapy for acute myeloid leukaemia (AML). A guide for patients'

ATRA and anthracycline based therapy for acute myeloid leukaemia (AML). A guide for patients (March 2018)

Leukaemia Care

All-trans retinoic acid (ATRA), known as Tretinoin (Vesanoid®) is the acid form of vitamin A, which is used with chemotherapy for induction of remission in patients with confirmed acute promyelocytic leukaemia (APL), a subtype of acute myeloid leukaemia. This booklet describes the use of ATRA along with the chemotherapy drugs idarubicin and mitoxantrone.

Cover image of 'Understanding chronic lymphocytic leukaemia (CLL)'

Understanding chronic lymphocytic leukaemia (CLL) (June 2018)

Macmillan Cancer Support

This booklet answers questions about the causes, symptoms, diagnosis, staging, and treatment of chronic lymphocytic leukaemia. It also covers feelings, self-help, and practical and financial support. Includes details of useful organisations and resources.

Cover image of 'Palbociclib (Ibrance ®) (Polish)'

Palbociclib (Ibrance ®) (Polish) (June 2018)

Macmillan Cancer Support

Palbociclib (Ibrance®) is a targeted therapy drug used to treat breast cancer that is oestrogen receptor positive and HER 2 negative. This factsheet describes what it is, how it is given, and possible side effects. 

Cover image of 'Prostate cancer [Nepali]'

Prostate cancer [Nepali] (May 2018)

Macmillan Cancer Support

This factsheet is about how prostate cancer is diagnosed and treated.

Cover image of 'Understanding cervical cancer'

Understanding cervical cancer (April 2018)

Macmillan Cancer Support

This booklet describes cancer of the cervix, how it develops, the symptoms, how it is diagnosed, further tests following diagnosis, and the treatment options. It also explores the emotional aspects. Includes details of the financial help and benefits available, and useful organisations

Cover image of 'Understanding non-Hodgkin lymphoma'

Understanding non-Hodgkin lymphoma (January 2018)

Macmillan Cancer Support

This booklet aims to provide a better understanding of non-Hodgkin lymphomas, their diagnosis and treatment. It also has sections on feelings and sources of practical and financial support. Includes details of useful organisations.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm